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Post-ischaemic Organ Dysfunction: A Review 
S. Homer-Vanniasinkam, J. N. Crinnion and M. J. Gough* 
Vascular Surgical Unit, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, U.K. 
Objectives: The aim of this review is to consider the pathophysiology of ischaemia-reperfusion in organs that may be 
affected by either its local or remote consequences. Potential therapeutic strategies are also considered. 
Design: A general discussion of the biochemical (including oxygen free radicals, complemenL cytokines) and cellular 
events (endothelial cells, neutrophils) responsible for the mediation of reperfusion injury is presented, with special 
consideration of the organ-specific differences affecting the myocardium, central nervous ystem, gut, liver, kidney and 
skeletal muscle. Similarly, events which promote remote organ injury are described. 
Conclusions: Although it is recognised that prolonged ischaemia results in tissue and organ damage, the concept of 
reperfusion-induced tissue injury, defined as tissue damage occurring as a direct consequence of revascularisation, is 
relatively recent. Such events may increase the morbidity and mortality of patients undergoing vascular econstruction, 
trauma surgery and transplantation. A clear understanding of the factors responsible for its development is therefore 
vital if protocols that reduce its impact are to be developed. 
Introduction 
Although it is well recognised that prolonged isch- 
aemia causes tissue necrosis, the concept hat sub- 
sequent revascularisation may also be harmful 
(reperfusion i jury) is more recent. This phenomenon 
has been termed "oxygen paradox", and it is likely 
that events which are initiated in the ischaemic period 
are promulgated following reperfusion, exerting wide- 
spread effects on tissues and organ systems. Whilst 
the severity of reperfusion injury is dependent upon 
the duration of preceding ischaemia, 02 concentration, 
temperature and pH also influence the extent of tissue 
damage. Finally, it is apparent that the susceptibility 
to, and the mediation of, reperfusion i jury differs in 
various organs, and this will be discussed in detail. 
Biochemistry of Reperfusion Injury 
During ischaemia, ATP catabolism yields ADP, AMP, 
adenosine, inosine and hypoxanthine. The resulting 
energy loss deranges cell membrane ionic pump func- 
tion, thus increasing cytosolic Ca + + concentration (Fig. 
1). The latter promotes conversion of xanthine de- 
hydrogenase to its oxidase form in many tissues in- 
cluding lung, liver and gut, reversing the normal 9:1 
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ratio of dehydrogenase:oxidase uring ischaemia. The 
latter, in the presence of 02, promotes hypoxanthine 
metabolism with the concomitant release of the super- 
oxide free radical. 1Under physiological conditions the 
latter undergoes dismutation, via intracellular super- 
oxide dismutase, to form hydrogen peroxide, from 
which H20 is produced by the action of catalase. 
Hydrogen peroxide may also react with superoxide 
radicals (the Haber-Weiss and Fenton reactions) to 
form the highly reactive hydroxyl (OH-) free radical, 
which is also generated following a reaction between 
superoxide radicals and EDRF (nitric oxide). 2Other 
sources of oxygen-free radicals (OFR) include activated 
neutrophils (PMN), mitochondrial NADH de- 
hydrogenase, auto-oxidation of catecholamines, and 
arachidonic acid metabolism. 
These free radicals, particularly the hydroxyl radical, 
initiate lipid peroxidation ofcell membranes, releasing 
arachidonic acid and lipid peroxyi free radicals. The 
former is metabolised by cyclo-oxygenase (throm- 
boxane A2, prostaglandins El, I2) or lipoxygenase (le- 
ucotrienes GTB4, C4, D4, E4) to release vasoactive 
eicosanoids, whilst lipid peroxyl radicals promote fur- 
ther lipid peroxidation. 3 The resulting cellular dys- 
function (loss of cell membrane integrity, enzyme 
inactivation, DNA scission) culminates in cytolysis 
and tissue necrosis. 4 
Experimentally, OFR scavengers (superoxide dis- 
mutase, desferoxamine, dimethylthiourea), inhibitors 
of lipid peroxidation (21-aminosteroids) and TxA2 and 
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Fig. 1. Biochemistry of ischaemia-reperfusion. ATP, adenine triphosphate; Ca2+, calcium; XD, xanthine dehydrogenase; XO,xanthine 
oxidase; HX, hypoxanthine; X, xanthine; AA, arachidonic acid; PAF, platelet-activating factor; TxA2, thromboxane A~; LT, leucotrienes; 
02-, superoxide radical; H202, hydrogen peroxide; OH-, hydroxyl radical. 
LTB4 receptor antagonists have been used to examine 
the mediation of reperfusion injury in a variety of 
models. 
High intracellular Ca ++ levels also have a pivotal 
role in cell damage during ischaemia-reperfusion. In 
mitochondria it impairs the tetravalent reduction of 
02 to water with diversion to univalent reduction and 
OFR production. S Furthermore, in myocardial isch- 
aemia it accelerates ATP depletion which precedes 
lethal myocardial injury. 6 Impaired Ca + + homeostasis 
continues during reperfusion, with further rises in 
myocardial Ca + + content. The harmful effects of this 
"calcium paradox" are prevented by a period of Ca + + 
free perfusion. 7 
Cellular Events in Reperfusion Injury 
Recent work has examined the importance of both 
endothelium and PMN in the pathogenesis of re- 
perfusion injury. PMN-endothelial adhesion is the 
primary event which allows these cells to participate 
in the biochemical events described above. Circulating 
PMNs may be activated by pro-inflammatory cyto- 
kines, LTB4 and the complement activation product 
C5a, which up-regulate the surface adhesion molecules 
CD11/CD18 (Fig. 2). These bind to endothelial ligands 
(ICAM-1 and E-selectin) prior to transmigration i to 
the area of tissue injury. Subsequently, PMNs cause 
further injury by releasing OFR and protease nzymes. 
Experimentally, monoclonal antibodies (moAb) to the 
adhesion molecules and their ligands ameliorate some 
of the detrimental effects of reperfusion, whilst sCR1 
(recombinant soluble form of human complement re- 
ceptor) modifies the response to complement ac- 
tivation. 
Neutrophil recruitment is regulated by the micro- 
vascular endothelium where adhesive interactions 
with marginated PMN first occur. At rest it is hypo- 
adhesive for PMN, 8 although once activated by in- 
jurious stimuli, either directly or via release of 
histamine, thrombin or cytokines, itproduces avariety 
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Fig. 2. Schematic diagram of neutrophil-endothelial interaction. (A) 
Initial cell activation with the release ofinflammatory mediators and 
expression f adhesion molecules on the cell surface. (B) Neutrophil 
rolling and adhesion to the endothelium. (C) Neutrophil trans- 
migration across the endothelium and subsequent tissue interaction. 
EC, endothelial ceil; OFR, oxygen free radicals; PMN, poly- 
morphonuclear white cells (neutrophils); TxA2, thromboxane A2; 
LTB4, leucotriene B4; PAF, platelet-aceivating factor; ICAM-1, in- 
tercellular adhesion molecule-I; CD11/CD18, neutrophil integrin 
(adhesion molecule); IL-8, interleukin--8. 
of mediators 9 (e.g. LTB4, TxA2, PAF, IL-8) and expresses 
adhesion molecules (P-selectin, E-selectin). ~°'a~ Altered 
microvascular permeability, cytoskeletal changes and 
endothelial cell swelling are characteristic of endo- 
thelial injury during reperfusion, resulting in tissue 
oedema nd reduced capillary blood flow. 
Organ Specific Injury 
Myocardium 
Acute myocardial ischaemia results in changes in myo- 
cardial structure, metabolic status and function. Whilst 
ATP depletion could explain these events, their rapid 
onset implicates other factors (intracellular acidosis 
and impaired sarcoplasmic Ca + + transport). The myo- 
cardial response to prolonged, subcritical ischaemia is 
also interesting, because adaptive mechanisms reduce 
regional blood flow and systolic wall thickening with- 
out causing irreversible damage. These changes re- 
cover following reperfusion 12 and represent the 
"hibernating myocardium". 13 
Whilst modern therapy for sudden coronary artery 
occlusion may prevent some of its complications, a 
number of adverse events may occur following re- 
perfusion. These include arrhythmias, myocardial 
stunning, lethal reperfusion injury and accelerated 
necrosis. 14 
Reperfusion arrhythmias occur within seconds of 
restoring coronary artery flow, and vary from pre- 
mature beats to ventricular fibrillation. Experimentally, 
OFR scavengers prevent these arrhythmias, whilst 
radical-generating systems promote their occur- 
rence. 15"~6 Additionally, disturbances in lipid meta- 
bolism and cellular ionic fluxes may also be important. 
Myocardial "stunning", ~7 a sublethal injury, rep- 
resents astate of persistent, but reversible, dysfunction 
during reperfusion. Its duration is dependent upon, 
but significantly exceeds that oL the antecedent isch- 
aemia, and OFR release and impaired Ca ++ homeo- 
stasis are critically important. They result in 
uncoupling of excitation-contraction, altered cellular 
Mg + + concentration a d temporary disruption of myo- 
cyte cytoskeletal microtubules38 The clinical sequelae 
of stunning include regional wall abnormalities in 
unstable angina, and depressed left ventricular func- 
tion and contractility following cardiac surgery and 
transplantation. 
"Lethal reperfusion injury" is also associated with 
cellular Ca ÷+ overload, together with PMN activation 
and mitochondrial injury. Whilst OFR may promote 
these events, antioxidants do not consistently reduce 
infarct size, 19 perhaps reflecting inadequate scavenging 
of OFR, which may be released for extended periods 
during reperfusion. 
No-reflow (impaired capillary perfusion) is a con- 
sistent feature of lethal reperfusion i jury 2° which may 
be the result of endothelial disruption, red cell rouleaux 
formation, myocyte swelling and capillary plugging 
by PMN. Destruction of EDRF by OFR may also impair 
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blood flow during early reperfusion, and thus the 
endothelium regulates myocardial perfusion by pro- 
ducing both relaxing and constricting factors. 21 How- 
ever, neither PMN-free perfusates nor anti-neutrophil 
serum consistently prevent no-reflow7 2'23 and whilst 
its clinical relevance is unclear, prevention may limit 
infarct size and enhance myocardial drug delivery. 24 
Finally, "accelerated necrosis" is a consequence of
extended periods of global ischaemia 25 rather than a 
complication of reperfusion, although the latter ac- 
celerates further myocardial destruction, promoting 
intramyocardial haemorrhage and aneurysm for- 
mation. 
Recent work has examined the role of inflammatory 
mediators in myocardial reperfusion i jury. It is likely 
that the inflammatory process is initiated uring early 
reperfusion and contributes to the ultimate injury (Fig. 
2). Thus, capillary plugging by PMN and OFR release 
following PMN-endothelial dhesion may reduce per- 
fusion by both mechanical and biochemical means. 
Furthermore, direct adhesion between PMN and car- 
diac myocytes may also Occur,  26 thus explaining the 
potent cytotoxicity of their secretory products. Whilst 
PMN-myocyte adhesion requires activation of both cell 
types, endothelial dhesion occurs following activation 
of only one cellular component. Thus, cytokines uch 
as IL-1, IL-6, TNFa and LPS, which activate both 
myocytes and PMN, and endothelial IL-8 (PMN ac- 
tivation, down-regulation of neutrophil LECAM-1), 
may regulate these events. 
Complement activation also occurs following myo- 
cardial ischaemia, 27 and correlates with PMN ac- 
cumulation within ischaemic myocardium. 28 Its 
significance is unclear, however. 
Despite these findings it is not certain that re- 
perfusion causes death of viable myocytes. Never- 
theless, prompt myocardial revascularisation does 
confer a clinical benefit, and an understanding of its 
possible ill-effects is essential if further eductions in 
post-ischaemic morbidity are to be achieved. 
microvilli formation 34may also contribute to this phe- 
nomenon. 
OFR, generated by the microvascular endothelium 
and cerebral arteriolar myocytes9  almost certainly 
mediate tissue injury in cerebral ischaemia-re- 
perfusion. 36In a feline model they influence micro- 
vascular blood flOW 37 by promoting sustained 
arteriolar dilatation and a reduced vasoconstrictor re- 
sponse to hypocapnia. The response of large cerebral 
vessels to hypocapnia is not endothelium-dependent, 
however, 38and thus it is likely that OFRs have a 
direct effect upon vascular smooth muscle. In contrast, 
reversal of acetylcholine-induced vasodilatation also 
occurs and is likely to reflect annihilation of EDRF by 
these radicals. Furthermore, OFRs also override the 
vasodilator response to increased cerebral adenosine 
content during ischaemia, g9 because pre-treatment 
with OFR scavengers eversed these changes. 
Neutrophils also effect changes in cerebral perfusion 
following capillary plugging, which occurs in the ab- 
sence of tissue infiltration during early reperfusion. 4° 
Thus, in experimental models PMN depletion and 
moAb to CD11/CD18 and ICAM reduce infarct size 
and increase regional blood f low. 41'42 Further evidence 
of a role for PMN is also suggested by increased LTB 4 
receptor binding during reperfusion, which mirrors 
subsequent cerebral infiltration by PMN. This implies 
that these receptors are located on accumulated neutro- 
phils. 
Lipid peroxidation, also a function of activated 
PMN, results in increased eicosanoid production after 
transient carotid occlusion. 43'44 Inhibition of this with 
a 21-aminosteroid ameliorates delayed hypoperfusion 
and reduced the volume of cortical infarction in a 
rodent model. 45 Similarly, spinal cord injury was de- 
creased in a rabbit model of aortic occlusion. 46Thus, 
lipid peroxidation appears to promote tissue damage 
during CNS ischaemia-reperfusion, although these 
compounds may also prevent antioxidant depletion 
and Ca + + dyshomeostasis. 47 
Central nervous system 
"No-reflow" also occurs in the brain following periods 
of ischaemia. 29In addition, "delayed post-ischaemic 
hypoperfusion" may follow initial hyperaemia, which 
is promoted by accumulation of lactic acid and vaso- 
active compounds (ADP, AMP) during the period of 
ischaemia. 3°'31 This appears to be the consequence of
an ischaemic neuronal degeneration which impairs 
vasomotor egulation. Cerebral oedema, 32capillary 
plugging by platelets and neutrophils 33and endothelial 
Gut 
The significance of reperfusion in the gut has been 
elegantly demonstrated by Parks and Granger, who 
showed that 3 h ischaemia nd i h reperfusion resulted 
in greater mucosal injury than 4 h ischaemia lone. 48 
Similarly, the benefits of initial anoxic perfusion sup- 
ports the concept that reoxygenation of ischaemic 
intestine paradoxically culminates in cell death .  49 
Intestinal mucosa has a rich supply of xanthine 
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oxidase and is thus a potential source of OFR. Fur- 
thermore, the proportion of xanthine oxidase (to de- 
hydrogenase) increases from 19-61% following 3h 
ischaemia in rat intestine. 5°This is followed by a burst 
of oxidant production within 2-5 rain of reperfusion. 
Similarly, administration of superoxide dismutase to 
a rodent shock model restores planchnic prostacyclin 
production and increases intestinal blood flow. 51 
Neutrophil OFR and protease (eg elastase, col- 
lagenase) release also promotes intestinal reperfusion 
injury, and thus in a feline model PMN influx during 
ischaemia resulted in a seven-fold increase in gut 
myeloperoxidase activity, escalating to an 18-fold in- 
crease during reperfusion. The importance of PMN 
has been further confirmed in a rat ex vivo model in 
which restoration of the 02 supply to the gut by a 
PMN-free perfusate had a protective ffect, which was 
lost when PMN were present9 Thus, although 02 is 
essential for OFR production, PMN are also critical in 
effecting tissue damage. This is likely to be related to 
their potent NADPH oxidase system, which reduces 
molecular O2 to the superoxide anion. 
The relative contributions of recruited and resident 
PMN to intestinal dysfunction during reperfusion has 
also been investigated. In a feline model an anti-CD11/ 
CD18 moAb was given either long-term or acutely to 
suppress resident and circulating PMN, respectively. 
Gut myeloperoxidase levels were decreased by long- 
term administration, aswas mucosal permeability fol- 
lowing 3h ischaemia/1 h reperfusion. Acute dosing 
had no effect on either parameter, and thus resident 
PMN may be more important in altering mucosal 
function during reperfusion. ~4These differing roles 
might be related to anatomical or functional differences 
between the cells, although the closer proximity of 
resident PMN to the mucosa may influence their capa- 
city to produce OFR and proteases. 
Intravital microscopy of the intestinal micro- 
circulation during reperfusion indicates that PMN 
margination and rolling precede ndothelial dhesion 
and diapedesis following chemotactic activationY 
Whilst rolling depends upon the selectin adhesion 
molecules (LECAM-1, LAM-1, gp90MEC), activation is 
promoted by C5a, platelet-activating factor, LTB 4 and 
the bacterial peptide fMLP. It may also be modulated 
by adenosine, histamine, calcitonin and gene-related 
peptide, which interact o enhance/suppress PMN 
function, s8'59 Similarly, a specific A2 adenosine receptor 
participates in the various steps rolling, adhesion and 
emigration. 6° 
Clinically, intestinal ischaemia-reperfusion occurs 
following surgery for bowel obstruction, after reversal 
of haemorrhagic shock, in necrotising enterocolitis 
and during surgery for acute mesenteric schaemia or 
thoraco-abdominal aneurysm repair. Whilst the car- 
diac complications of gut reperfusion may be espe- 
cially troublesome, other sequelae include abnormal 
intestinal homeostasis and bacterial translocation, 
which may promote multisystem organ failure. 61 
Liver and kidney 
The investigation of hepatic and renal reperfusion 
injury has been motivated by the advent of organ 
transplantation. All transplanted livers undergo some 
degree of cell loss during cold ischemia, although 
reperfusion reduces the hepatocyte volume by a fur- 
ther 20%. 62 
The four components of hepatic preservation-re- 
perfusion injury comprise sinusoidal lining cell (SLC) 
injury, white cell adhesion, platelet adhesion and in- 
creased coagulation. 6; During cold preservation SLC 
are shed into the sinusoidal lumen, the severity of cell 
loss being determined by the duration of ischaemia. 
This time interval also influences further cell death 
following reperfusion, which is promoted by white 
cell-SLC adhesion. The latter, involving both PMN and 
lymphocytes, i  controlled by cytokine-dependent up- 
regulation of adhesion molecules. 63Thus, tumour nec- 
rosis factor (TNF) and IL-6 are released uring isch- 
aemia-reperfusion a d anti-TNF antiserum reduces 
both hepatic and remote (pulmonary) injury. 64'65 
Platelet-SLC adhesion following reperfusion also 
mirrors the degree of preservation i jury and is ex- 
acerbated by the presence of platelets within the har- 
vested organ. Furthermore, hepatic rewarming prior 
to reperfusion increases platelet adhesion and ac- 
tivation. 66 Finally, enhanced pro-coagulant activity also 
occurs during reperfusion. Suppression of thrombo- 
modulin, hypoxia-induced synthesis of membrane- 
associated factor X activator, and loss of endothelial 
cell surface heparin sulphate proteoglycan appear to 
be responsible. 63 
Post-transplant renal failure has been studied ex- 
tensively. Thus, in vitro OFR production by rat prox- 
imal tubule epithelial cells occurs after hypoxia- 
reoxygenation 67 with OFR scavengers, glutathione, and 
vitamin E reducing injury. Surprisingly, the role of 
PMN in renal reperfusion i jury appears controversial. 
Klausner et al. showed that a combination of anti- 
neutrophil serum and a leucotriene synthetase in- 
hibitor reduced TxA2 and LTB4 production, increased 
renal blood flow, and reduced both serum creatinine 
and the severity of acute tubular necrosis in a rat 
model. 68 Similarly, Linas confirmed that PMN ac- 
tivation was a prerequisite for functional injury during 
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reperfusion. 69 In contrast, Thornton et al. reported that 
neither antineutrophil serum nor an anti-CD11b/ 
CD18mAb prevented injury in either rat or rabbit 
models of renal reperfusion. 7° These differing con- 
clusions might be related to the timing of the studies. 
Whilst Linas investigated changes during initial reflow, 
Thornton et al. focused on the early phase of acute 
renal failure. Thus, PMN may have a transitory role 
upon revascularisation without influencing the overall 
severity of reperfusion i jury. 
The role of other adhesion molecules in mediating 
renal damage has also been reviewed. 7~ Small amounts 
of ICAM-1 are constitutively expressed by large vessel 
endothelial cells, peritubular capillaries, glomeruli and 
mesangial cells, whilst VCAM-1 can be detected in 
the parietal cells of Bowman's capsule and occasional 
endothelial cells (large vessels, peritubular capillaries). 
During graft rejection, ICAM-1 expression by proximal 
tubule cells (especially on the luminal surface) in- 
creases dramatically, as do circulating ICAM-1 levels. 
Similarly, endothelial VCAM-1 expression is increased, 
apparently at sites of T-cell accumulation. 72 In contrast, 
E-selectin is not expressed by the kidney either con- 
stitutively or during rejection. These findings com- 
plement hose demonstrating a striking delay in graft 
rejection following anti-ICAM-1 moAb administration 
in a primate, 78 although the effect in man was mar- 
ginal. 74 
Posbischaemic muscle blood flow in rodents follows 
a triphasic pattern characterised by initial low reflow, 
a period of improved perfusion (relative reperfusion), 
and a final decline to negligible levels. 81 Whilst low 
reflow was prevented by OFR scavengers (pre- 
servation of EDRF), the final fall in perfusion persisted, 
and therefore other factors must be relevant. 82
Lipid peroxidation of cell membranes and Ca ++ 
dyshomeostasis al o occur within reperfused muscle. 
Thus, Ca ++ entry blockers reduce enhanced cellular 
permeability, whilst a 21-aminosteroid and specific 
LTB 4 and TxA2 receptor antagonists improved post- 
ischaemic muscle function. 84-86 In particular, the LTB4 
receptor antagonist prevented muscle necrosis and 
reduced reperfusion oedema. 87
Post-reperfusion PMN sequestration within skeletal 
muscle leads to the release of a further burst of OFR 
and proteolytic enzymes, particularly elastase, which 
encourages PMN transmigration (Fig. 2). 88 Thus, both 
PMN depletion and elastase inhibition 89 improve 
muscle viability following revascularisation. Similarly, 
moAb to CD11/CD18 reduce microvascular per- 
meability, PMN sequestration a d vascular esistance, 
and improve muscle perfusion. 9°'9~ Complement ac- 
tivation also promotes PMN stimulation, and hence 
administration of sCR1 prevents leukocyte adhesion 
and improves muscle perfusion and viability. 92'93 
Skeletal muscle 
The ability of skeletal muscle to synthesise ATP an- 
aerobically confers a relative resistance to ischaemic 
injury. However, once energy stores are depleted, re- 
perfusion following acute ischaemia (embolism, 
thrombosis, prolonged vascular surgery, trauma) may 
be complicated by muscle oedema, necrosis and im- 
paired function, with 10-20% of patients ultimately 
requiring amputation. Marked oedema may also pre- 
cipitate a "compartment syndrome" and further nec- 
rosis. Whilst the local injury reflects microcirculatory 
failure, release of mediators from the limb may pro- 
mote remote organ injury which contributes tothe high 
mortality in these patients. Hence, primary amputation 
has a lower mortality than revascularisation. 76 
The cellular and biochemical events during isch- 
aemia-reperfusion are similar to those already de- 
scribed. Thus, xanthine oxidase is present within 
muscle parenchyma and capillary endothelium, and 
OFR within ischaemic muscle and the venous effluent 
of reperfused limbs. Furthermore, OFR scavengers 
may ameliorate the muscle in jury.  77-8° 
Remote organ injury 
Following ischaemia-reperfusion systemic release of 
various mediators may effect injury at distant sites, 
with the kidneys, lungs, liver and heart being at risk 
of compromise. Thus, early work showed that re- 
vascularisation of ischaemic limbs released K +, H + 
and myoglobin into the circulation and resulted in 
impaired renal, cardiac and pulmonary function. Other 
mediators (TxA2, LTB4) are also liberated, resulting in 
transient pulmonary hypertension, leukosequestration 
and increased capillary permeability. 94 Inhibition of 
these eicosanoids greatly attenuates pulmonary in- 
jury. 9S These events mirror the transient (24h) pul- 
monary injury occurring following lower torso 
ischaemia during aortic aneurysm repair. 96 
Further studies with sCR1 have confirmed the role 
of the complement system in promoting pulmonary 
oedema following hindlimb ischaemia-reperfusion, al- 
though leukosequestration was not affected. 97Sim- 
ilarly increased levels of TNF-a, IL-1, and IL-6 occur 
following hindlimb reperfusion and may influence 
PMN-mediated remote organ injury. Thus, both pul- 
monary vascular ICAM-1 and neutrophil CD11b/ 
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CD18 expression are increased uring reperfusion, 
whilst enhanced lung permeability is prevented by 
blocking these adhesion molecules. 99'1°° Other man- 
oeuvres which reduce remote pulmonary injury in- 
clude the use of L-arginine analogues, which inhibit 
phagocytic nitric oxide synthetase. Although this sug- 
gests a deleterious role for NO, it is almost certainly 
related to a reduction in free radical production. 
Intestinal reperfusion is an important effector of 
distant organ injury and multisystem organ failure 
(MSOF), 61 of which pulmonary injury is a major com- 
ponent. Although TNF release by hepatic macrophages 
in response to gut endotoxin appears to be of crucial 
importance, ~°I an anti-TNF antibody did not inhibit 
pulmonary leukosequestration. However, the latter 
was prevented by inactivation of xanthine oxidase in 
a rat model of intestinal reperfusion, ~°2'I°3 and thus 
the pathogenesis of remote organ injury is clearly 
multi factorial. 
Further evidence for a humoral mediator of lung 
injury following intestinal reperfusion is provided by 
a study in which portal vein plasma from rats subjected 
to superior mesenteric artery occlusion and re- 
perfusion caused ATP depletion in pulmonary endo- 
thelial cell monolayers, although both cellular 
microfilament architecture and viability were pre- 
served. TM 
The clinical importance of mesenteric re- 
vascularisation i  promoting MSOF has been ex- 
amined in a study of 18 patients undergoing surgery 
for intestinal ischaemia, l°sMortality following emer- 
gency surgery was 75% (3/4) from a combination of 
pulmonary, hepatic and renal failure. In contrast, 86% 
of patients survived elective procedures, with two 
deaths from intractable lung failure and either liver 
or kidney failure. 
Finally, "whole body" ischaemia-reperfusion may 
occur following resuscitation from haemorrhagic or 
septic shock. Experimentally, moAb to adhesion 
molecules reduce organ dysfunction and subsequent 
morbidity and mortality. I°6 
Conclusions 
It is clear that reperfusion may initiate both local and 
systemic tissue injury following visceral re- 
vascularisation. Whilst the cellular and molecular 
mechanisms of cell injury have been fairly well de- 
lineated, current studies are focusing on the in- 
tracellular signalling pathways which promote these 
events. This should allow the design of safe and specific 
intervention strategies that will prevent post-ischaemic 
visceral injury. 
References 
1 McCORD JM. Oxygen-derived free radicals in postischemic 
tissue injury. N Engl J Med 1985; 312: 159-163. 
2 BECKMAN JS, BECKMAN TW, CHEN J, MARSHALL PA, FREEMAN 
BA. Apparent hydroxyl radical production by peroxynitrite: 
implications for endothelial injury from nitric oxide and super- 
oxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624. 
3 ERNSTER L. Biochemistry ofreoxygenation injury. Crit Care Med 
1988; 16: 947-953. 
4 MEERSON FZ, KAGAN VE, KOZHOV YP et al. The role of lipid 
peroxidation i  the pathogenesis of/Lschemic damage and the 
antioxidant protection of the heart. Basic Res Cardiol 1982; 77: 
465-485. 
5 PARR DR, WIMSHURST JM, HARRIS EI. Calcium-inducted dam- 
age of rat heart mitochondria. Cardiovasc Res 1975; 9: 366-372. 
6 STEENBERGEN C, MURPHY E, WATTS JA, LONDON RE. Correlation 
between cytosolic free calcium contracture, ATP, and irreversible 
ischemic injury in perfused rat heart. Circ Res 1990; 66: 135-146. 
7 ZIMMERMAN ANE, DAEMS W, HULSMANN WC, SNIJDER J, WISSE 
E, DURRER D. Morphological changes of heart muscle caused by 
successive perfusion with calcittrn-free and calcium-containing 
solutions (calcium paradox). Cardiovasc Res 1967; 1: 201-209. 
8 GIMBRONE MA, WHEELER ME, BEVlLACQUA MP. Endothelial- 
dependent mechanisms of leukocyte adhesion. J Japan Athero- 
sclerosis Soc 1989; 16: 1101-1104. 
9 MCINTYRE TM, ZIMMERMAN GA, PRESCOTT SM. Leukotrienes 
C4 and D 4 stimulate human endothelial cells to synthesize 
platelet-activating factor and bind neutrophils. Proc NatI Acad 
Sci USA 1986; 83: 2204-2208. 
10 McEvER RP, BECKSTEAD JH, MOORE KL, MARSHALL-COLSON L, 
BAINTON DE GMP-140, a platelet alpha-granule membrane 
protein, is also synthesized by vascular endothelial cells and is 
localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-106. 
11 BEVILACQUE MP, PROBER JS, WHEELER ME, COLTRAN RS, 
GIMBTONE MA. Interleukin-1 acts on cultured human vascular 
endothelium to increase the adhesion of polymorphonuclear 
leukocytes, monocytes and related leukocyte cell lines. J Clin 
Invest 1985; 76: 2003-2011. 
12 MATSUZAKI M, GALLAGHER KP, KEMPER WS, WHITE F~ Ross 
J. JR Sustained regional dysfunction produced by prolonged 
coronary stenosis: gradual recovery after reperfusion. Cir- 
culation 1983; 68: 170-182. 
13 RAHIMTOOLA SH. The hibernating rnyocardium. Am Heart J 
1989; 117: 211-221. 
14 HEARSE DJ, BOLLI R. Reperfusion induced injury: mani- 
festations, mechanisms, and clinical relevance. Cardiovascular 
Res 1992; 26: 101-108. 
15 BERNIER M, HEARSE, DJ, MANNING AS. Reperfusion-induced 
arrhythmias and oxygen-derived free radicals: studies with 
"anti-free radical" interventions and a free radical generating 
system in the isolated perfused rat heart. Circ Res 1986; 58: 
331-340. 
16 Kt~SAMA Y, BERNIER M, HEARSE DJ. The exacerbation of re- 
perfusion arrhythmias by sudden oxidant stress. Circ Res 1990; 
67: 481-489. 
17 BRANWALD E, KLONER RA. The stunned myocardium: pro- 
longed, post-ischemic ventricular dysfunction. Circulation 1982; 
66: 1146-1149. 
18 SATO H, HORI M, KITAKAZE Met  aL Reperfusion after brief 
ischemia disrupts the microtubule network in canine hearts. 
Circ Res 1993; 72: 361-375. 
19 R~IMER KA, MURRY CE, RICHARD VJ. The role of neutrophil 
and free radicals in the ischernic-reperfused heart: why the 
confusion and controversy? J Mol Cell Cardiol 1989; 21: 1225- 
1239. 
29 KLONER RA, GANOTE, CE, JENNINGS RB. The "no-reflow" phe- 
nomenon after temporary coronary occlusion in the dog. J Clin 
Invest 1974; 54: 1496-1508. 
21 FURCHGOTT RF, VANHOUTTE PM. Endothelium-derived r laxing 
and contracting factors. FASEB J 1989; 3: 2007-2018. 
Eur J Vasc Endovasc Surg Vol 14, September 1997 
202 S. Homer-Vanniasinkam et al. 
22 ELZ JS, NAYLER WG. Contractile activity and reperfusion-in- 
duced calcium gain after ischemia in the isolated rat heart. Lab 
Invest 1988; 58: 653-659. 
23 CARLSON RE, SCHOTT RJ, BOnA AJ. Neutrophil depletion fails 
to modify myocardial no reflow and functional recovery after 
coronary reperfusion. ] Am Coll Cardiol 1989; 14: 1803-1813. 
24 KLONER RA. No reflow revisited. J Am Coil CardioI 1989; 14: 
1814-1815. 
25 HEARSE DJ, HUMPHREY SM, BULLOCK GR. The oxygen paradox 
and the calcium paradox: two facets of the same problem? J 
Mol Cell Cardiol 1978; 10: 641-668. 
26 ENTMAN ML, YOUKER K, SHAPPELL SB et al. Neutrophil ad- 
herence to isolated adult canine myocytes: evidence for a CD19- 
dependent mechanism. J Clin Invest 1990; 85: 1497-1506. 
27 HILL JH, WARD PA. The phlogistic role of C3 leukotactic frag- 
ment in myocardial infarcts of rats. J Exp Med 1971 1971; 133: 
885-900. 
28 ROSSEN RD, SWAIN JL, MICHAEL LH, WEAKLEY S, GIANNINI E, 
ENTMAN ML. Selection accumulation of the first component of 
complement and leukocytes in ischemic anine heart muscle: a 
possible initiator of an extra-myocardial mechanism of ischemic 
injury. Circ Res 1985; 57: 119-130. 
29 AMES A, WRIGHT RL, KOWADA M, THURSTON JM, MAJNO G. 
Cerebral ischemia. II. The no-reflow phenomenon. Am ] Pathol 
1968; 52: 437-453. 
30 LEvY DE, VAN UITERT RL, PIKE CL. Delayed postischemic 
hypoperfusion: a potentially damaging consequence of stroke. 
Neurology 1979; 29: 1245-1252. 
31 MILLER CL, LAMPARD DG, ALEXANDER K, BROWN WA.. Local 
cerebral blood flow following transient cerebral ischemia. I. 
Onset of impaired reperfusion within the first hour following 
global ischemia. Stroke 1980; 11: 534-541. 
32 MELLERGARD P~ BENGTSSON E SMITH ML, RIESENFELD V/SIEJO 
BK. Time course of early brain edema following reversible 
forebrain ischemia in rats. Stroke 1989; 20: 1565-1570. 
33 GROGAARD B, SCHURER L, GERDIN B, ARFORS KE. Delayed 
hypoperfusion after incomplete forebrain ischemia in the rat: 
the role of polymorphonuclear leukocytes. J Cereb Blood Flow 
Metab 1989; 9: 500-505. 
34 DIETRICH WD, BUSTO R, GINSBERG MD. Cerebral endothelial 
micr0villi: formation following global forebrain ischemia. J
Neuropathol Exp Neurol 1984; 43: 72-83. 
35 KONTOS CD, WEI EP, WILLIAMS JI, KONTOS HA, POVLISCHOCK JT. 
Cytoehemical detection of superoxide in cerebral inflammation 
and ischemia. Am J Physiol 1992; 263: H1234-H1242. 
36 ARMSTEAD WM, MIRRO R, BUSIJA DW, LEZER CW. Postischemic 
generation of superoxide anion by newborn pig brain. Am J 
Physiol 1988; 255: H401-H403. 
37 NELSON CW, WI~I EP, POVLISHOCK J% KONTOS HA, MOSKOWITZ 
MA. Oxygen radicals in cerebral ischemia. Am J Physiol 1992; 
263: H1356-H1362. 
38 TODA N, HATANO Y~ MORI K. Mechanisms underlying response 
to hypercapnia and bicarbonate ofisolated og cerebral arteries. 
Am J Physiol 1989; 257: H141-H146. 
39 WINN HR, RoBIn R, BERNE RM. Brain adenosine production in 
the rat during 60 seconds of ischemia. Circ Res 1979; 45: 486-492. 
40 DEL ZOPPO GJ, SCHMID-SCHONBEIN GW, MORI E, COPELAND DR, 
CHANG C-M. Polymorphonuclear leukocytes occlude capillaries 
following middle cerebral artery occlusion and reperfusion in 
baboons. Stroke 1991; 22: 1276-1283. 
41 BEDNAR MM, RAYMOND $1 McAoLIFFE T, LODGE PA, GROSS CE. 
The role of neutrophils and platelets in a rabbit model of 
thromboembolic stroke. Stroke 1991; 22: 44-50. 
42 CLARK WM, MADDEN KP, ROTHLEIN R, ZIVlN JA. Reduction of 
central nervous ystem ischemic injury by monoclonal ntibody 
to intercellular adhesion molecule. J Neurosurg 1991; 75: 623-627. 
43 YOSHIDA S, INOH S, ASANO T et al. Effect of transient ischemia 
on free fatty acids and phospholipids in the gerbil brain. J 
Neurosurg 1980; 53: 323-331. 
44 GAUDET RJ, LEVINE L. Transient cerebral ischemia and brain 
prostaglandins. Biochem Biophys Res Commun 1979; 86: 893-901. 
45 XOE D, SLIVKA A, BOCHAN AM. Tirilazad reduces cortical 
infarction after transient but not permanent focal cerebral isch- 
emia in rats. Stroke 1992; 23: 894-899. 
46 FOWL RJ, PATTERSON RB, GEWIRTZ RJ, ANDERSON DK. Protection 
against postischemic spinal cord injury using a new 21-amino- 
steroid. J Surg Res 1990; 48: 597-600. 
47 HALL ED, PAZARA KE, BRAUGHLER JM. Effects of tirilazad 
mesylate on postischemic brain lipid peroxidation and recovery 
of extracellular calcium in gerbils. Stroke 1991; 22: 361-366. 
48 PARKS D, GRANDER N. Contributions of ischemia and re- 
perfusion to mucosal lesion formation. Am J Physiol 1986; 250: 
G749-G753. 
49 KORTHUIS RJ, SMITH JK, GARDEN DL. Hypoxic reperfusion 
attenuates postischemic microvascular injury. Am J Physio11989; 
256: H315-H319. 
50 PARKS DA, WILLIAMS TK, BECKMAN JS. Conversion of xanthine 
dehydrogenase to oxidase in ischemic rat intestine: a re- 
evaluation. Am J Physiol 1988; 254: G768-G774. 
51 MYERS SI, HERNANDEZ R. Oxygen free radical regulation of rat 
splanchnic blood flow. Surgery 1992; 112: 347-354. 
52 GRISHAM MB, HERNANDEZ LA, GRANGER DN. Xanthine oxidase 
and neutrophil infiltration in intestinal ischemia. Am J Physiol 
1986; 251: G567-G574. 
53 BROWN ME Ross AJ III, DASHER J, TURLEY DL, ZIEGLER MM, 
O'NEILL JA JR. The role of leukocytes in mediating mucosal 
injury of intestinal ischemia/reperfusion. J Pediatr Surg 1990; 
25: 214-217. 
54 KOBES P, HONTER J, GI~A_NGER DN. Ischemia/reperfusion-in- 
duced feline intestinal dysfunction: importance of granulocyte 
recruitment. Gastroenterology 1992; 103: 807-812. 
55 RAUD J, LINDBOM L. Leukocyte rolling and firm adhesion in 
the microcirculation. Gastroenterology 1993; 104: 310-314. 
56 LEY K, GAEHTGENS P, FENNIE C, SINGER MS, LASKY LA, ROSEN 
SD. LEC-CAM 1 mediates leukocyte rolling in mesenteric ven- 
ules in vivo. Blood 1991; 77: 2553-2555. 
57 SMEDEGARD n. Mediators of vascular permeability in in- 
flammation. Prog Appl Microcirc 1985; 7: 96-112. 
58 KAMINSKI PM, PROCTOR KG. Attenuation of no-reflow phe- 
nomenon, neutrophil activation and perfusion injury in in- 
testinal microcirculation by topical adenosine. Circ Res 1989; 
65: 426-435. 
59 RAUD J, LUNDEBERG T~ BRODDA-JANsEN G, THEODORSSON E, 
HEDQVIST P. Potent antMnflammatory action of calcitonin gene- 
related peptide. Biochem Biophys Res Commun 1991; 180: 1429- 
1435. 
60 ASAKO H, WOLF RE, GRANGER DN. Leukocyte adherence in rat 
mesenteric venules: effects of adenosine and methotrexate. 
Gastroenterology 1993; 104: 31-37. 
61 CARRICO CJ, MEAKINS JL, MARSHALL JC, FRY D, MAIER RV. 
Multiple organ failure syndrome. Arch Surg 1986; 121: 196-208. 
62 THURMAN RG, MARZI I, SEITZ G, THEIS J, LEMASTERS JJ, ZIM- 
MERMANN FA. Hepatic reperfusion injury following orthoptic 
liver transplantation in the rat. Transplantation 1988; 46: 502-506. 
63 CLAVI~N P-A, HARVEY PCR, STRASBERG SM. Preservation and 
reperfusion i juries in liver allografts. Transplantation 1992; 53: 
957-978. 
64 COLLETTI LM, REMICK DG, BURTCH GD, KUNKEL SL, STRIETER 
R-M, CAMPBELL DA JR. Role of tumour necrosis factor-a in the 
pathophysiologic alterations after hepatic ischemia/reperfusion 
injury in the rat. J Clin Invest 1990; 85: 1936-1943. 
65 SAKR MF, McCLAIN CJ, GAVALER JS, ZETTI GM, STARZL TE, 
VAN THIEL DH. FK 506 pre-treatment is associated with reduced 
levels of tumor necrosis factor and interleuking 6 following 
hepatic ischemia/reperfusion. J Hepatol 1993; 17: 301-307. 
66 CYwEs R, PACKHAM MA, TIETZE Let  al. Role of platelets in 
hepatic allograft preservation i jury in the rat. Hepatology 1993; 
18: 635-647. 
67 GREENE EL, PALLER MS. Xanthine oxidase produces 02- in 
posthypoxic injury of renal epithelial cells. Am J Physiol 1992; 
263: F251-F255. 
68 KLAUSNER JM, PATERSON IS, GOLDMAN Get  al. Postischemic 
Eur J Vasc Endovasc Surg Vol 14, September 1997 
Post-ischaemic Organ Dysfunction 203 
renal injury is mediated by neutrophils and leukotrienes. Am J 
Physiol 1989; 256: F794-F802. 
69 LINAS SL, 8HANLEY PF, WHITTENBURG D, BERGER E, REPINE JE. 
Neutrophils accentuate ischemia-reperfusion n isolated per- 
fused rat kidneys. Am f Physiol 1988; 255: F728-F735. 
70 THORNTON MA, WINN R, ALPERS CE, ZAGER RA. An evaluation 
of the neutrophils as a mediator of in vivo renal ischemic- 
reperfusion injury. Am J Pathol 1989; 135: 509-515. 
71 BRADY HR. Leukocyte adhesion molecules and kidney diseases. 
Kidney Int 1994; 45: 1285-1300. 
72 BRISCOE DM, POBER JS, HARMON WE, COTRAN RS. Expression 
of vascular cell adhesion molecule-1 in human renal allografts. 
J Am Soc Nephol 1992; 3: 1180-1185. 
73 COSIMI AR, CONTI D, DELMONICO FL et al. In vivo effects of 
monoclonal ntibody to ICAM-1 (CD54) in nonhuman primates 
with renal allografts. J Immunol 1990; 144: 4604-4612. 
74 TOLKOFF-RUBIN N, ROTHLEIN K SCHARSCHMIDT Let  aI. hn- 
munosuppression with anti-ICAM-1 (CD54) mAb in renal al- 
lograft recipients (abstract). J Am Soc Nephrol 1991; 2: 820. 
75 PANETTA T, THOMPSON JE, TALKINGTON CM et aL Arterial em- 
bolectomy: 34 year experience with 400 cases. Surg Clin N Am 
1986; 6: 339-353. 
76 BLAISDELL FW, STEELE M, ALLEN RE. Management of acute 
lower extremity arterial ischemia due to embolism and throm- 
bosis. Surgery 1978; 84: 822-834. 
77 CHOUDHURY NA, SAKAGUCHI S, KOYANO K et al. Free radical 
injury in skeletal muscle ischemia nd reperfusion. J Surg Res 
1991; 51: 392-398. 
78 LINDSAY T, WALKER PM, MICKLE DA, ROMASCHIN AD. Measure- 
ment of hydroxy-conjugated dienes after ischemia-reperfusion 
in canine skeletal muscle. Am J Physiol 1988; 254: H578-H583. 
79 IBRAHIM B, STOWARD PJ. The histochemical localisation of xan- 
thine oxidase. Histochem J 1978; 10: 615-617. 
80 JARASCH ED, BRUNDER G, HEID HW. Significance of xanthine 
oxidase in capillary endothelial cells. Acta Physiol Scand 1986; 
Suppl 548: 39-46. 
81 HARDY SC, HOMER-VANNIASINKAM S, GOUGH MJ. The triphasic 
pattern of skeletal muscle blood flow in reperfusion i jury: an 
experimental model with implications for surgery on the acutely 
ischaemic lower limb. Eur J Vasc Surg 1990; 4: 587-590. 
82 HARDY SC, HOMER-VANNIASINKAM S, GOUGH MJ. Effect of free 
radical scavenging on skeletal muscle blood flow during post- 
ischemic reperfusion. Br J Surg 1992; 79: 1289-1292. 
83 PAUL J, BEKKER AY, DURAN WN. Calcium entry blockade pre- 
vents leakage of macromolecules induced by ischemia-re- 
perfusion in skeletal muscle. Circ Res 1990; 66: 1636-1642. 
84 HOMER-VANNIASINKAM S, HARDY SC, GOUGH MJ. Reversal 
of post-ischaemic changes in skeletal muscle blood flow and 
viability by a novel inhibitor of lipid peroxidation. Eur J Vasc 
Surg 1992; 7: 41-45. 
85 HOMER-VANNIASINKAM S, GOUGH MJ. Modulation of lipid me- 
diators in the prevention of muscle infarction and oedema 
during reperfusion after ischaemia. Br J Surg 1992; 79: 442. 
86 HOMER-VANNIASINKAM S, CRINNION JN, GOUGH MJ. Role of 
thromboxane A2 in muscle injury following ischaemia. Br J 
Surg 1994; 81: 974-976. 
87 HOMER-VANNIASINKAM S, GOUGH MJ. The role of leukotrienes 
in controlling post-ischaemic skeletal muscle function. Vascular 
Surgery 1993; 27: 585-590. 
88 ZIMMERMAN BJ, GRANGER DN. Reperfusion-induced l ukocyte 
infiltration: role of elastase. Am J Physiol 1990; 259: H390-H394. 
89 CRINNION JN, HOMER-VANNIASINKAM S, HATTON R, PARK1N 
SM, GOVGH MJ. The role of neutrophil depletion and elastase 
inhibition in modifying skeletal muscle reperfusien i jury. Car- 
diovasc Surg 1994; 2: 749-753. 
90 CARDEN DL, KORTHUIS RJ. Role of neutrophil elastase in post- 
ischemic granulocyte xtravasation and microvascular dys- 
function in skeletal muscle. FASEB J 1990 49: A1248. 
91 CRINNION JR, VANNIASINKAM St PARKIN SM, GOUGH MJ. The 
role of neutrophil-endothelial adhesion in skeletal muscle re- 
perfusion injury. Br J Surg 1996 83: 251-254. 
92 RUBIN BB, SMITH At LIAUW Set al. Complement activation and 
white cell sequestration i  post-ischemic skeletal muscle. Am J 
Physiol 1990; 259: H525-H531. 
93 PEMBERTON M, ANDERSON G, VETVICKA V~ JUSTUS DE, Ross 
GD. Microvascular effects of complement blockade with soluble 
recombinant CR1 on ischemia/reperfusion injury of skeletal 
muscle. J Immunol 1993; 150: 5104-5113. 
94 ANNER I-I, KAUFMAN RP JR z VALERI CK SHEPRO D, HECHTMAN 
HB. Reperfusion of ischemic lower limbs increases pulmonary 
microvascular permeability. J Trauma 1988; 28: 607~10. 
95 ANNER H, KAUFMAN RP, KOBZIK K et aI. Pulmonary leuko- 
sequestration i duced by hindlimb ischemia. Ann Surg 1987; 
206: 162-167. 
96 PATERSON IS, KLAUSNER JM, PUGATCH R et aI. Non-cardiogenic 
pulmonary oedema fter abdominal aortic surgery. Ann Surg 
1989; 209: 231-236. 
97 LINDSAY TF, HILL, J, ORITZ F et aI. Blockade of complement 
activation prevents local and pulmonary albumin leak after 
lower torso ischemia-reperfusion. A n Surg 1992; 216: 677-683. 
98 SEEKAMP A, WARREN JS, REMICK DG, TILL GO, WARD PA. 
Requirements for tumour necrosis factor-a nd interleukin-1 in 
limb ischemia/reperfusion njury and associated lung injury. 
Am J Pathol 1993; 143: 453-463. 
99 SEEKAMP A, MULLIGAN MS, TILL GO et al. Role of B2 integrins 
and ICAM-1 in lung injury following ischemia-reperfusion of 
rat hind limbs. Am J Pathol 1993; 143: 464-472. 
100 SEEKAMP A, MULLIGAN MS, TILL GO, WARD PA. Requirements 
for neutrophil products and L-arginine in ischemia-reperfusion 
injury. Am J Pathol 1993; 142: 1217-1226. 
101 CATY MG, GuICE KS, OLDHAM KT, REMICK DG, KUNKEL SI. 
Evidence for tumor necrosis factor-induced pulmonary micro- 
vascular injury after intestinal ischemia-reperfusion injury. Ann 
Surg 1990; 212: 694-700. 
102 TERADA LS, DORMISH JJ, SHANLEY PF, LEFF JA, ANDERSON 
BO, REPINE JE. Circulating xanthine oxidase mediates lung 
neutrophil sequestration after intestinal ischemia-reperfusion. 
Am J. Physiol 1992; 263: L394-L401. 
103 POGGETTI RS, MOORE FA, MOORE EE, KOEIKE K, BANERJEE A. 
Simultaneous liver and lung injury following gut ischemia is 
mediated by xanthine oxidase. J Trauma 1992; 32: 723-727. 
104 GERKIN TM, OLDHAM KT, GUICE KS, HINSHAW DB, RYAN 
US. Intestinal ischemia-reperfusion injury causes pulmonary 
endothelial cell ATP depletion. Ann Surg 1993; 217: 48-56. 
105 HARWARD TRS, BROOKS DL, FLYNN TC, SEEGER JM. Multiple 
organ dysfunction after mesenteric artery revascularization, f 
Vasc Surg 1993; 18: 459-469. 
106 VEDDER NB, WINN RK, RICE CL, CHI EYz ARFORS KE, HARLAN 
JM. A monoclonal antibody to the adherence-promoting leu- 
kocyte glycoprotein CD18, reduces organ injury and improves 
survival from hemorrhagic shock and resuscitation i rabbits. 
J Clin Invest 1988; 81: 933-944. 
Accepted 27 January 1997 
Eur J Vasc Endovasc Surg Vol 14, September 1997 
